Study of Temsirolimus, Topotecan, and Bortezomib

Clinical trial NCT00770731 · COMPLETED

Trial details

NCT number: NCT00770731
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-09-01
Primary completion: 2012-11-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.